Karolina A. Aberg

Karolina A. Aberg

Auto-generated profile, based on publicly available information

Karolina A. Aberg

Center for Biomarker Research and Precision Medicine, Virginia Commonwealth University, Richmond, VA, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2018 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
WCWilliam E. Copeland
William E. Copeland
LSLilly Shanahan
Lilly Shanahan
JHJennifer Hinesley
Jennifer Hinesley
RCRobin F. Chan
Robin F. Chan
KAKarolina A. Aberg
Karolina A. Aberg
ECE. Jane Costello
E. Jane Costello
Exposure to traumatic events (as defined by Diagnostic and Statistical Manual of Mental Disorders [DSM] criterion A for posttraumatic stress disorder)1 is a common experience of childhood, with more than 60% of children exposed by age 16 years and more than 30% exposed to multiple events.2,3 Exposure to traumatic events is associated with posttraumatic stress and other common childhood emotional and behavioral problems.2-5 An extensive literature links childhood trauma, particularly maltreatment, to adult psychopathology and impairment.6-10 These studies, however, have generally relied on reports of adults recalling events that occurred decades earlier.11 Such retrospective recalls are prone to simple forgetting or recall bias depending on the individual’s current mental health.11-13 This study uses a prospective community sample followed up repeatedly from childhood to adulthood to test whether childhood trauma has lasting effects on adult mental health and multidomain functioning.

1 August 2018 in American Journal of Psychiatry
Verified
Journal Article
Closed access
LHLaura K.M. Han
Laura K.M. Han
MAMoji Aghajani
Moji Aghajani
SCShaunna L. Clark
Shaunna L. Clark
RCRobin F. Chan
Robin F. Chan
MHMohammad W. Hattab
Mohammad W. Hattab
BPBrenda W.J.H. Penninx
Brenda W.J.H. Penninx

1 March 2014 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
KAKarolina A. Aberg
Karolina A. Aberg
JMJoseph L. McClay
Joseph L. McClay
SNSrilaxmi Nerella
Srilaxmi Nerella
SCShaunna Clark
Shaunna Clark
GKGaurav Kumar
Gaurav Kumar
EOEdwin J. C. G. van Den Oord
Edwin J. C. G. van Den Oord
The methylation of DNA cytosine residues at the carbon 5 position is a common epigenetic modification that is often found in the sequence context CpG. Investigations of these markings provide a promising complement to schizophrenia studies of DNA sequence variation. First, methylation can directly affect gene expression, so it may capture additional variation in disease susceptibility. Indeed, specific epimutations have already been associated with human diseases, including psychiatric disorders.1 Second, methylation studies may advance our understanding of schizophrenia. For example, they can potentially account for a variety of features, such as its episodic nature.2,3 Third, the translational potential is considerable. For example, epigenetic markings are modifiable by pharmaceutical interventions, making them possible new drug targets.4

9 May 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
KÅKarolina Åberg
Karolina Åberg
PSPeter Saetre
Peter Saetre
NJNiclas Jareborg
Niclas Jareborg
EJElena Jazin
Elena Jazin
The quaking viable mouse mutation (qk v ) is a deletion including the 5′ regulatory region of the quaking gene ( Qki ), which causes body tremor and severe dysmyelination in mouse. The function of the human quaking gene, called quaking homolog KH domain RNA-binding (mouse) ( QKI ), is not well known. We have previously shown that QKI is a new candidate gene for schizophrenia. Here we show that human QKI mRNA levels can account for a high proportion (47%) of normal interindividual mRNA expression variation (and covariation) of six oligodendrocyte-related genes ( PLP1 , MAG , MBP , TF , SOX10 , and CDKN1B ) in 55 human brain autopsy samples from individuals without psychiatric diagnoses. In addition, the tightly coexpressed myelin-related genes ( PLP1 , MAG , and TF ) have decreased mRNA levels in 55 schizophrenic patients, as compared with 55 control individuals, and most of this difference (68–96%) can be explained by variation in the relative mRNA levels of QKI-7kb , the same QKI splice variant previously shown to be down-regulated in patients with schizophrenia. Taken together, our results suggest that QKI levels may regulate oligodendrocyte differentiation and maturation in human brain, in a similar way as in mouse. Moreover, we hypothesize that previously observed decreased activity of myelin-related genes in schizophrenia might be caused by disturbed QKI splicing.

16 October 2013 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
JMJoseph L. McClay
Joseph L. McClay
KAKarolina A. Aberg
Karolina A. Aberg
SCShaunna L. Clark
Shaunna L. Clark
SNSrilaxmi Nerella
Srilaxmi Nerella
GKGaurav Kumar
Gaurav Kumar
EOEdwin J.C.G. Van Den Oord
Edwin J.C.G. Van Den Oord
The central importance of epigenetics to the aging process is increasingly being recognized. Here we perform a methylome-wide association study (MWAS) of aging in whole blood DNA from 718 individuals, aged 25–92 years (mean = 55). We sequenced the methyl-CpG-enriched genomic DNA fraction, averaging 67.3 million reads per subject, to obtain methylation measurements for the ∼27 million autosomal CpGs in the human genome. Following extensive quality control, we adaptively combined methylation measures for neighboring, highly-correlated CpGs into 4 344 016 CpG blocks with which we performed association testing. Eleven age-associated differentially methylated regions (DMRs) passed Bonferroni correction (P-value < 1.15 × 10−8). Top findings replicated in an independent sample set of 558 subjects using pyrosequencing of bisulfite-converted DNA (min P-value < 10−30). To examine biological themes, we selected 70 DMRs with false discovery rate of <0.1. Of these, 42 showed hypomethylation and 28 showed hypermethylation with age. Hypermethylated DMRs were more likely to overlap with CpG islands and shores. Hypomethylated DMRs were more likely to be in regions associated with polycomb/regulatory proteins (e.g. EZH2) or histone modifications H3K27ac, H3K4m1, H3K4m2, H3K4m3 and H3K9ac. Among genes implicated by the top DMRs were protocadherins, homeobox genes, MAPKs and ryanodine receptors. Several of our DMRs are at genes with potential relevance for age-related disease. This study successfully demonstrates the application of next-generation sequencing to MWAS, by interrogating a large proportion of the methylome and returning potentially novel age DMRs, in addition to replicating several loci implicated in previous studies using microarrays.

1 June 2013 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
KAKarolina A. Aberg
Karolina A. Aberg
YLYoufang Liu
Youfang Liu
JBJozsef Bukszár
Jozsef Bukszár
JMJoseph L. McClay
Joseph L. McClay
AKAmit N. Khachane
Amit N. Khachane
EOEdwin J. van Den Oord
Edwin J. van Den Oord
Schizophrenia (SCZ) is a major public health problem1 that ranks ninth in the global burden of illness.2 Of a large set of prenatal and antenatal risk factors, having a first-degree relative with SCZ is one of the most important,3 and genetic factors account for most of this familial risk.4 Identifying the specific genetic variants that increase susceptibility is crucial to improve our understanding of SCZ and has the potential to address the urgent need for new drug targets.5